Is Screening of Young Asymptomatic MEN1 Patients Necessary?
#1327
Introduction: Recent clinical practice guidelines recommend that routine screening of MEN1 mutation carriers should start at the age of 5 years to detect MEN1-associated tumors which is controversial in the scientific community.
Aim(s): Evaluation of the occurrence of clinically relevant MEN1 organ manifestations in children(<18 years).
Materials and methods: A prospective and retrospective collected data base of MEN1 patients who undergo an annual screening program was retrospectively analyzed for organ manifestations of MEN1 patients <18 years. The annual costs of a screening visit were calculated based on the German Diagnosis Related Groups.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Manoharan J, Lopez C, Albers M, Bollmann C, Slater E,
To read the full abstract, please log into your ENETS Member account.